About Vitro Biopharma

September 18, 2020 0 Comments

About Vitro Biopharma

About Vitro Biopharma 

Vitro Biopharma is a publicly traded stem cell technology company dedicated to providing high-quality commercialized cell lines, media, stem cell products and stem cell technology for applications in stem cell research, drug discovery and stem cell therapies. 

Vitro Biopharma Has Been Around For Over 25 Years 

Vitro Biopharma has been developing several novel cell culture media formulations over the last 25 years as well as providing human stem cell lines and related primary cells for use in research, drug discovery/development and pre-clinical studies.  Vitro Biopharma is presently focused on adult stem cells known as mesenchymal stem cells or MSCs. The discovery of embryonic stem cells capable of differentiation into any cell type of the body was largely responsible for the development of modern stem cell technology. Vitro Biopharma ensures all cell lines are carefully tested for purity, integrity, and contaminates. 

Vitro Biopharma Certifications 

Vitro Biopharma provides high-quality stem cells produced under strict quality control in a cGMP, ISO9001 & ISO13485 Certified environment. Vitro Biopharma's umbilical cord AlloRx™ Stem Cells and stem cell growth media MSC-Gro™ have been used in the treatment of hundreds of patients without adverse events and show efficacy in the treatment of COPD, osteoarthritis, multiple sclerosis and Alzheimer’s disease. Out of years of research, Vitro Biopharma developed patent-pending and proprietary lines of umbilical cord derived stem cells. AlloRx™ Stem Cells are now being used in offshore regenerative medicine clinical trials. Vitro Biopharma has a patent-pending, proprietary and scalable manufacturing platform to provide stem cell therapies to critically ill Coronavirus patients. Vitro Biopharma's stem cells have been shown to be safe in Phase I protocols as they also gain evidence of efficacy. 

Vitro Biopharma Partnered With Fitore To Create Stemulife™ 

In late 2020, Vitro Biopharma partnered with the up-and-coming nutraceutical company Fitore Nutrition to create Stemulife™. Stemulife™ by Vitro Biopharma is a novel formulation of natural substances that have been shown to activate stem cells within the body promoting optimal health, along with epigenetic effects that allow proper DNA repair to occur. Stem cells reside throughout the body in an “inactive” state until injury or inflammation occur. The natural substances present in Stemulife™ keep the stem cells within your own body in an “active” state so these cells can help heal and provide therapy to the body. Stemulife ™ has been shown to activate, migrate, and reprogram stem cells. The stem cells then express higher levels of anti-aging genes, anti-inflammatory properties, and overall cellular health. 

Vitro Biopharma and InfiniVive MD 

Dr. Jack Zamora an oculofacial plastic surgeon and pioneer in plasma technology, partnered with Vitro BioPharma in early 2018 to create the InfiniVive product line for the aesthetic industry. InfiniVive MD was developed for plastic surgeons, cosmetic surgeons, nurses, and aestheticians as a cosmetic product from pure cells derived from the Wharton’s Jelly of a human umbilical cord. The serum is used for beautification and applied on the skin after a cosmetic service. 

InfiniVive is the world’s most unique cosmetic stem cell serum and aesthetic professionals are reporting they notice unprecedented skin-beautification results in as few as 14-days.

Vitro Biopharma’s AlloRx Stem Cells®

In July 2020, a critically ill patient was admitted to the emergency room with classic COVID-19 symptoms and had several comorbidities (one or more medical conditions) prior to admission. While intubated in the Intensive Care Unit (ICU) and under standard care and treatment, the patients conditioned worsened. The patient suffered a stroke and his kidneys and liver function began to fail. The patient then switched care and was treated by Vitro Biopharma's AlloRx Stem Cells® and experienced a resolution of multiple organ failure, recovery from coma, and restoration of the neurological, pulmonary, liver, and renal function. 

This study was authorized by the FDA through an investigational Drug Application (eIND) for emergency use under expanded access granted to GIOSTAR, who is Vitro Biopharma's partner in stem cell therapy for COVID-19 using AlloRx Stem Cells® as a therapeutic agent. 




Also in Stem Cells

About Jack Zamora MD
About Jack Zamora MD

September 09, 2020 0 Comments

Jack Zamora, M.D. is an oculofacial plastic surgeon and a pioneer in plasma treatments and stem cell technology. Specializing in innovative cosmetic applications for the face, eyes, and body, Dr. Zamora is a leader in minimally invasive treatments. He is the medical director of several offices throughout
Colorado, offering select surgical and non-surgical facial refinement, skin rejuvenation, and body sculpting services.

Read More

Learn more

Receive emails about updates, events, education, and special deals!